RN7SL495P

Across TCGA pan-cancer cohorts, RN7SL495P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL495P data layer compared with 1 for mutation status.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RN7SL495P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL495P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

CESC, THYM, and THCA are the cancer types where RN7SL495P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.203	0.798	.001	54	view →
THYM	OS	Tertile	All	0.549	0.968	<.001	54	view →
THCA	OS	Tertile	II,III,IV	0.586	0.903	.005	39	view →
ESCA	OS	Tertile	All	0.322	0.718	.001	27	view →
ACC	DFS	Tertile	II,III,IV	0.226	0.725	.009	18	view →
OV	DFS	Tertile	All	0.664	0.154	.040	12	view →
KIRC	OS	Tertile	All	0.408	0.637	.036	9	view →
STAD	DFS	Tertile	All	0.500	0.669	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL495P–CESC (OS)

Open the CESC breakdown →